Clinical data of Medigene's dendritic cell (DC) vaccines presented at AACR conference
Medigene AG (MDG1, Frankfurt, Prime Standard) announces that early clinical data of its dendritic cell (DC) vaccines wer…
Medigene AG (MDG1, Frankfurt, Prime Standard) announces that early clinical data of its dendritic cell (DC) vaccines wer…
The Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established a Priority Programm…
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that 18-month (78-week) results of a Phase 3 trial of Praluen…
Medigene AG (MDG1, Frankfurt, Prime Standard) announces that two presentations on its antigen-tailored dendritic cell (D…
Medigene AG (MDG1, Frankfurt, Prime Standard) today presents at the 14th International Conference on Progress in Vaccina…
Velphoro® (sucroferric oxyhydroxide) has received EU marketing authorisation from the European Commission for the contro…
. - Velphoro® (PA21) recommended for approval in the European Union for the treatment of hyperphosphatemia in adult Chr…
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer…
On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scienti…
Velphoro® (sucroferric oxyhydroxide) has received US Food and Drug Administration (FDA) approval for the control of seru…